MakroCare at Emerging Regions Oncology Trials in Morristown, NJ
Newark, NJ 10/15/2012 11:49 AM GMT (TransWorldNews)
Meet MakroCare, one of the sponsors of the 5th Oncology Clinical Trials in Emerging Regions conference held at Hyatt Morristown at Headquarters Plaza, Morristown, NJ on 22-23 October, 2012.
Increasing number and quality of clinical research trials are being conducted in emerging regions bring important new data about the oncology clinical research that has not previously been available. However, although there are numerous benefits, actually identifying countries or regions, securing and working with local investigators and adherence to local regulatory are just some of the many challenges faced when planning and executing oncology clinical trials in emerging regions.
This conference will assess the current ever changing operational, regulatory and logistical challenges being faced when conducting oncology clinical trials in emerging regions as well as will look at the future role that emerging regions will play.
Topics will include –
•Regional case studies for oncology clinical trials for India, China, Eastern Europe, Russia, Latin America and Middle East
•Challenges of clinical trial design relevant to a cancer specific population
•Conducting global site selection/feasibility studies
•Clinical trials of oncology Biosimilars
•Challenges of global patient recruitment
•Operational strategies to ensure profitability in oncology clinical trials
•Establishing relationships with local CROs
•Challenges of establishing a successful supply chain in emerging regions
MakroCare is an international drug development and commercialization services firm that is dedicated to efficient, high-level performance in combination with unparalleled client satisfaction supporting from USA, Europe and Asia. MakroCare has 5 subsidiaries/divisions – Consulting, CRO, SMO, DDi and Commercialization. MakroCare has teams positioned worldwide in these divisions supporting product life cycle management, regulatory affairs, risk management, regulatory compliance, trial management (clinical, late phase), monitoring, biometrics (CDM, EDC, Biostat, SAS programming), Medical Writing (Regulatory, Clinical), QA audits, Drug safety / Pharmacovigilance, Site management, Patient Recruitment, Informatics (EDC, CTMS, IVRS), Commercialization, and Marketing/Sales.